Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMC 3754640)

Published in J Clin Microbiol on July 10, 2013

Authors

Veronika Tchesnokova1, Mariya Billig, Sujay Chattopadhyay, Elena Linardopoulou, Pavel Aprikian, Pacita L Roberts, Veronika Skrivankova, Brian Johnston, Alena Gileva, Irina Igusheva, Angus Toland, Kim Riddell, Peggy Rogers, Xuan Qin, Susan Butler-Wu, Brad T Cookson, Ferric C Fang, Barbara Kahl, Lance B Price, Scott J Weissman, Ajit Limaye, Delia Scholes, James R Johnson, Evgeni V Sokurenko

Author Affiliations

1: Department of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.

Articles citing this

Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev (2014) 2.26

The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev (2015) 2.06

A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother (2014) 1.48

Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother (2013) 1.40

Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol (2014) 1.18

Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli. Antimicrob Agents Chemother (2015) 1.07

The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. Clin Infect Dis (2016) 0.95

Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One (2014) 0.95

Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field. J Infect Dis (2015) 0.87

Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2014) 0.85

A Novel 7-Single Nucleotide Polymorphism-Based Clonotyping Test Allows Rapid Prediction of Antimicrobial Susceptibility of Extraintestinal Escherichia coli Directly From Urine Specimens. Open Forum Infect Dis (2016) 0.80

Emergence of Antibiotic Resistance-Associated Clones Among Escherichia coli Recovered From Newborns With Early-Onset Sepsis and Meningitis in the United States, 2008-2009. J Pediatric Infect Dis Soc (2015) 0.80

Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy. Urology (2015) 0.79

The role of Sequence Type (ST) 131 in adult community-onset non-ESBL-producing Escherichia coli bacteraemia. BMC Infect Dis (2014) 0.77

Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis. Open Forum Infect Dis (2016) 0.77

Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection. PLoS One (2017) 0.77

The Niche for Escherichia coli Sequence Type 131 Among Veterans: Urinary Tract Abnormalities and Long-Term Care Facilities. Open Forum Infect Dis (2016) 0.76

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center. mSphere (2016) 0.76

Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate. Antimicrob Agents Chemother (2017) 0.75

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012. Infect Dis Ther (2017) 0.75

Articles cited by this

Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63

Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol (2006) 14.53

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57

Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med (2001) 8.26

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect (2003) 4.63

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56

Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res (2005) 2.98

Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol (2013) 2.08

High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00

Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis (2005) 1.87

Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis (1996) 1.78

Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am (1987) 1.34

Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother (2007) 1.32

Haplotype diversity in "source-sink" dynamics of Escherichia coli urovirulence. J Mol Evol (2006) 1.29

Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents (2010) 1.16

Electronic prediction rules for methicillin-resistant Staphylococcus aureus colonization. Infect Control Hosp Epidemiol (2010) 1.08

Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J Bacteriol (2012) 1.07

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J Antimicrob Chemother (2009) 1.00

Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin Proc (2012) 1.00

Can phylogenetic type predict resistance development? J Antimicrob Chemother (2011) 0.84

Escherichia coli clonal group A. Clin Infect Dis (2005) 0.79

Articles by these authors

Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother (2007) 7.81

Pyroptosis: host cell death and inflammation. Nat Rev Microbiol (2009) 7.63

Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun (2005) 6.31

Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol (2003) 5.18

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis (2010) 4.98

Population genetics of Vibrio cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak. MBio (2011) 4.70

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect (2003) 4.63

Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med (2013) 4.62

Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science (2006) 4.60

Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med (2013) 4.55

Bacterial adhesion to target cells enhanced by shear force. Cell (2002) 3.98

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother (2009) 3.79

Causes for the persistence of impact factor mania. MBio (2014) 3.77

Why has the number of scientific retractions increased? PLoS One (2013) 3.59

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56

The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol (2007) 3.55

Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol (2006) 3.44

Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin Infect Dis (2006) 3.43

Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A (2005) 3.35

Retracted science and the retraction index. Infect Immun (2011) 3.35

Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis (2007) 3.12

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis (2013) 2.85

Phylogeography of Francisella tularensis: global expansion of a highly fit clone. J Bacteriol (2009) 2.85

Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A (2008) 2.82

The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64

Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60

Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr (2002) 2.54

Industrial food animal production, antimicrobial resistance, and human health. Annu Rev Public Health (2008) 2.49

Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis (2002) 2.48

Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol (2003) 2.46

Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis (2004) 2.40

Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis (2007) 2.34

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32

Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol (2003) 2.25

Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol (2007) 2.25

Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol (2012) 2.22

NIH peer review reform--change we need, or lipstick on a pig? Infect Immun (2009) 2.21

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17

Multidrug-Resistant Staphylococcus aureus in US Meat and Poultry. Clin Infect Dis (2011) 2.11

A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science (2008) 2.10

In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted. Mol Microbiol (2006) 2.09

The alternative sigma factor sigmaE controls antioxidant defences required for Salmonella virulence and stationary-phase survival. Mol Microbiol (2002) 2.08

Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol (2005) 2.07

Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe (2013) 2.06

Silencing of xenogeneic DNA by H-NS-facilitation of lateral gene transfer in bacteria by a defense system that recognizes foreign DNA. Genes Dev (2007) 2.03

Predictors of urinary tract infection after menopause: a prospective study. Am J Med (2004) 2.03

Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol (2008) 2.02

Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog (2007) 2.01

Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01

High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00

Complications of Foley catheters--is infection the greatest risk? J Urol (2012) 2.00

Uncoiling mechanics of Escherichia coli type I fimbriae are optimized for catch bonds. PLoS Biol (2006) 2.00

Shear-dependent 'stick-and-roll' adhesion of type 1 fimbriated Escherichia coli. Mol Microbiol (2004) 1.97

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis (2011) 1.94

Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93

Characterization of six lipoproteins in the sigmaE regulon. J Bacteriol (2005) 1.91

Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin Microbiol (2011) 1.90

PoxA, yjeK, and elongation factor P coordinately modulate virulence and drug resistance in Salmonella enterica. Mol Cell (2010) 1.89

Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol (2003) 1.87

The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol Microbiol (2006) 1.86

Multiple targets of nitric oxide in the tricarboxylic acid cycle of Salmonella enterica serovar typhimurium. Cell Host Microbe (2011) 1.86

Molecular Analysis of Escherichia coli from retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis (2009) 1.86

Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting. Cell (2010) 1.85

Reforming science: methodological and cultural reforms. Infect Immun (2011) 1.85

Accelerated gene evolution through replication-transcription conflicts. Nature (2013) 1.82

Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol (2006) 1.82